Predictive modeling using a nationally representative database to identify patients at risk of developing microalbuminuria.

The predictive model provides new evidence about variables related with MA and may be used by clinicians to identify at-risk patients and to tailor treatment. The risk score developed may allow clinicians to measure a patient's MA risk.